Treatment-Related Regret Common in Prostate Cancer
A study of patients with localized prostate cancer showed that 13% reported treatment-related regret.
A study of patients with localized prostate cancer showed that 13% reported treatment-related regret.
Finding from a recent study could be used in patient counseling to promote healthier lifestyle choices to reduce the likelihood of prostate biopsy, according to investigators.
Nearly 74% of hemodialysis patients experienced pre-dialysis hyperkalemia within 1 year of enrollment in the Dialysis Outcomes and Practice Patterns Study, according to investigators.
In a randomized controlled study, adding metformin to androgen deprivation therapy for low-tumor-volume metastatic hormone-sensitive prostate cancer significantly delayed development of castration-resistant disease.
The risk for a first-time symptomatic kidney stone begins to increase in the second trimester and peaks 0 to 3 months after delivery, a study findings suggest.
Early detection of iron status may improve cardiovascular risk assessment in patients with CKD, according to investigators.
Of 25 patients with both obesity and gout who had elevated uric acid levels prior to bariatric surgery, 10 achieved therapeutic target levels of uric acid at 12 months after the surgery, according to investigators.
Patients older than 65 years whose salt intake is greater than 8 g/d have a nearly 44% decreased risk for end-stage kidney disease compared with those whose intake is less than 6 g/d, a study found.
Use of computed tomography and bone scans in low-risk prostate cancer cases has been in decline, but doctors continue to order these imaging modalities despite professional guidelines that do not recommend such use.
Whether successful treatment of depression reduces the risk for progression needs to be determined.